Q1 2026 AtriCure Inc Earnings Call Transcript
Good afternoon, and welcome to AtriCureâs first-quarter 2026 earnings conference call. This call is being recorded for replay purposes, and at this time, all participants are in listen-only mode. We will be facilitating a question-and-answer session following prepared remarks from AtriCureâs management.
I would now like to turn the call over to Marissa Bych from the Gilmartin Group for a few introductory comments.
Great, thank you. By now, you should have received a copy of the earnings press release. If you have not received a copy, please call 513-644-4484 to have one emailed to you.
Before we begin today, let me remind you that the companyâs remarks include forward-looking statements. Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond AtriCureâs control, including risks and uncertainties described from time to time in AtriCureâs SEC filings.
These statements include, but are not limited to, financial expectations and guidance,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
